This book provides a complete approach to the economics of financing medicines and policy implications for the efficiency and equity of health systems. In all health systems with majority public financing, pharmaceutical reimbursement is one of the key factors in policies of change and transformation of health services in order to face the future with guarantees of financial sustainability.
The initial chapters seek to answer questions about the efficiency with which the public sector intervenes in the pharmaceutical industry: Is the present system of drug patents efficient and fair? What would be the best way to control drug prices? Is it possible to encourage competition in this market for the patient's benefit? The remainder of the book provides evidence on the impact of instruments and policies aimed at rationalising and controlling pharmaceutical expenditure: What can we expect from the application of reference pricing systems? When, how and where should the user be made to share the cost of medicines? What economic and non-economic incentives should be applied to drug prescription?
Jaume Puig-Junoy has performed an invaluable task in creating a cohesive, and analytically rigorous book of specially commissioned chapters on this pertinent topic.
The Public Financing of Pharmaceuticals will appeal to academics and researchers involved in public finance, health policy, health economics, industrial organisation and the pharmaceutical markets in Europe and in the US, where there is increasing public interest in drug coverage. The book is also intended for a wide variety of professionals in the health industries and policymakers.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Edited by Jaume Puig-Junoy, Research Centre for Economics and Health (CRES), Department of Economics and Business, Pompeu Fabra University, Spain
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : Cotswold Internet Books, Cheltenham, Royaume-Uni
1st edition. A tidy copy in tight binding. Used - Very Good. VG hardback in VG dustjacket Used - Very Good. VG hardback in VG dustjacket. N° de réf. du vendeur BOOKS105244I
Quantité disponible : 1 disponible(s)
Vendeur : killarneybooks, Inagh, CLARE, Irlande
Hardcover. Etat : Fine. Etat de la jaquette : Near Fine. Hardcover, xiii + 255pp, index, NOT ex-library. Weight: 0.57kg / 1.24lb. A fine copy with clean and bright interior, firm binding, unmarked text; free of stamps and inscriptions. Dust jacket shows gentle creasing along the edges. --- This book provides a complete approach to the economics of financing medicines and policy implications for the efficiency and equity of health systems. In all health systems with majority public financing, pharmaceutical reimbursement is one of the key factors in policies of change and transformation of health services in order to face the future with guarantees of financial sustainability. The initial chapters seek to answer questions about the efficiency with which the public sector intervenes in the pharmaceutical industry: Is the present system of drug patents efficient and fair? What would be the best way to control drug prices? Is it possible to encourage competition in this market for the patient's benefit? The remainder of the book provides evidence on the impact of instruments and policies aimed at rationalising and controlling pharmaceutical expenditure: What can we expect from the application of reference pricing systems? When, how and where should the user be made to share the cost of medicines? What economic and non-economic incentives should be applied to drug prescription? -- Contents: 1. Introduction: Public Pharmaceutical Expenditure / Jaume Puig-Junoy; -- Part I -- 2. Incentives for Innovation in the Pharmaceutical Market / P. Ibern Regàs; 3. Price Regulation Systems in the Pharmaceutical Market / Jaume Puig-Junoy; 4. Regulation and Competition in Pharmaceutical Markets / Joan Ramon Borrell Arqué; 5. Mechanisms to Encourage Price Competition in the Pharmaceutical Market and their Effects on Efficiency and Welfare / J. Rovira Forns; -- Part II -- 6. Reference Pricing as a Pharmaceutical Reimbursement Mechanism / Guillem López Casasnovas; 7. Insurance in Public Financing of Pharmaceuticals / Beatriz González López-Valcárcel; 8. Economic Evaluation and Pharmaceutical Policy / José Luis Pinto Prades; 9. Prescriber Incentives / L. Cabiedes and V. Ortún; -- Part III -- 10. Economic Considerations Regarding Pharmaceutical Expenditure in Spain and its Financing / Guillem López Casasnovas; 11. Review of Economic Studies of the Pharmaceutical Industry Published Over the Last 20 Years by Spanish Economists / F. Lobo; Appendix: List of Economic Studies of the Pharmaceutical Industry and Pharmaceuticals Published Over the Last 20 Years by Spanish Economists; Index. N° de réf. du vendeur 002793
Quantité disponible : 1 disponible(s)
Vendeur : StainesBookhub, Weybridge, SURRE, Royaume-Uni
Etat : New. N° de réf. du vendeur SpeedList-1929
Quantité disponible : 5 disponible(s)
Vendeur : Basi6 International, Irving, TX, Etats-Unis
Etat : Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. N° de réf. du vendeur ABEOCT25-216479
Quantité disponible : 1 disponible(s)
Vendeur : Books Puddle, Woodside, NY, Etats-Unis
Etat : New. N° de réf. du vendeur 26134134573
Quantité disponible : 1 disponible(s)
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. N° de réf. du vendeur 126420210
Quantité disponible : 1 disponible(s)
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Etat : New. N° de réf. du vendeur 18134134567
Quantité disponible : 1 disponible(s)
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
Hardcover. Etat : Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book. N° de réf. du vendeur ERICA77318454208886
Quantité disponible : 1 disponible(s)